CannabisNewsBreaks

WednesdayOct 13, 2021 3:48 pm

CannabisNewsBreaks – Simply Sonoma Focusing on Multibillion Inflammation, Sleep Aids, Gut/Probiotic Health Markets

Simply Sonoma is a different kind of natural company building a reputation as a leader in plant-based medicinal health and beauty products. The company, which believes in an all-natural, organically sun-grown, plant-based medicinals, also provides consumers with science-based education on cannabidiol (“CBD”) for disease and lifestyle needs. CBD, the second most prevalent of the active ingredients of cannabis, is gaining attention as a potentially effective therapy for many uses, including inflammation, an area that Simply Sanoma is heavily focused on. “According to Allied Market Research, the global pain management and inflammation market is expected to reach nearly $92 billion by…

Continue Reading

WednesdayOct 13, 2021 3:32 pm

CannabisNewsBreaks – Sugarmade Inc. (SGMD) on Course to Quadruple Distribution Footprint, Establish Cultivation Operations

Sugarmade (OTC: SGMD), an innovator in the dynamic California cannabis sector, has signed a definitive agreement to obtain three non-storefront California cannabis licenses from the Los Angeles Department of Cannabis Regulation (“DCR”), along with corresponding licenses from the California Bureau of Cannabis Control (“BCC”). Each of the licenses can be used for up to three of the five categories of licensed cannabis-related business activities allowed under the terms of these licenses: retail delivery, manufacturing, distribution, transport-only, and cultivation. “The company noted that by using each license for a combination of retail delivery of cannabis products with supply chain distribution of…

Continue Reading

WednesdayOct 13, 2021 3:02 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Expands Footprint, GMP Certifications to Three

Flora Growth (NASDAQ: FLGC) is currently seeking revenue-generating acquisitions and strategic partnerships that offer a larger distribution network, amplify revenue growth and complement its human capital. “In recent months, Flora has announced three major transactions — Vessel Brand, Koch & Gsell, and Hoshi International,” reads a recent article. The acquisition of Vessel Brand is expected to expand Flora’s premium brand and product portfolio while diversifying its global distribution channels. The acquisition of Koch & Gsell, which is expected to introduce Flora Growth’s products to the Swiss, European and Asian markets, promises to bring patented hemp cigarette manufacturing technology into new…

Continue Reading

WednesdayOct 13, 2021 2:40 pm

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Leveraging State-of-the-Art Facilities, Expertise in Rapidly Growing Market

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, is in a position to leverage its state-of-the-art facilities and expertise to manufacture its own beverage product lines and to provide white-label solutions to a growing list of third-party companies. This comes as a recent Expert Market Research (“EMR”) report projects that North America is likely to be the fastest-growing and largest marketplace for cannabis beverages and that the global market will grow at a 48% CAGR in the next five years. Thus, BevCanna is ideally situated. A recent article reads, “The…

Continue Reading

WednesdayOct 13, 2021 2:13 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Impressive Findings of Oral THC Absorption Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its recent oral tetrahydrocannabinol (“THC”) absorption study THC-A21-1 revealed that DehydraTECH(TM)-THC delivered via oral ingestion required only 15 minutes to deliver THC levels in blood plasma comparable to levels achieved at 45 minutes with concentration-matched controls. According to the update, DehydraTECH-THC delivered more THC into the bloodstream during the study than the industry standard medium chain triglyceride (“MCT” or “coconut oil”) based control formulation from the two-minute mark onwards, then dropped rapidly to the same level as the MCT control by the six-hour mark. “The…

Continue Reading

WednesdayOct 13, 2021 1:35 pm

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) to Move Forward with Regulatory Approval Process to Bring Hourglass(TM) to All Canadians

Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, today announced its entry into a formal collaboration with 6PAK Solutions Inc. and Medz Cannabis, Inc., 6PAK’s partner and license holder, to bring Grapefruit’s patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream to market throughout Canada. According to the update, the formal collaboration agreement cements the strategic alliance with 6PAK Solutions Inc., a well-respected Canadian cannabis manufacturer and arm of ATG Pharma Inc. Under the new alliance, Grapefruit will file its Notice of New Cannabis Product (“NNCP”) with Health Canada detailing the Hourglass production process, including integration of…

Continue Reading

TuesdayOct 12, 2021 2:06 pm

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Preliminary Q2 2022 Results

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage Company(TM), today announced that it anticipates topline revenue of approximately $15 million for the second quarter of fiscal year 2022. According to the update, this would be the best quarter on record and represent almost 50% year-over-year growth. In addition, the company reiterates full fiscal year 2022 revenue guidance of $62 million and will officially report its results for the full second quarter of fiscal year 2022 in November. “We anticipate the second quarter sales of fiscal 2022 will be a…

Continue Reading

TuesdayOct 12, 2021 1:28 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Featured in ‘Stock2Me’ Podcast

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in the latest episode of the “Stock2Me Podcast,” an IBN (InvestorBrandNetwork) solution to provide specialized content distribution via widespread syndication channels. Lexaria’s CEO and Chairman Chris Bunka joined the latest episode to discuss the company’s business model, his professional background and the team behind Lexaria, as well as the company’s recent transformative steps to position it for accelerated growth. “Our company kind of had a rebirth in January 2021. … We completed a 1-for-30 reverse stock split,” Bunka explained. “That was really hard, and just…

Continue Reading

TuesdayOct 12, 2021 10:51 am

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Subsidiary Receives Cannabis Cultivation License, Commences Grow Operations

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, announced that its subsidiary, Red White & Bloom Florida LLC, has received approval to begin growth operations at its 45,000-square-foot greenhouse in Apopka, Florida. The company has completed phase one of its cultivation strategy and is in the midst of a three-phase development plan for two Florida cultivation centers. The centers are part RWBYF’s plan to produce adequate inventory for existing and new dispensary openings planned for Q1 2022. The company had plants at the greenhouse ready to plant as soon as approval…

Continue Reading

MondayOct 11, 2021 2:26 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Providing Reliable, Consistent Dose Administration and Monitoring Devices

RYAH Group (CSE: RYAH), a connected device and big data and technology company, offers a suite of precision intake control and management devices that provide a practical way to execute volume control guidelines safely. In a company blog post, discussed in a recent article, RYAH noted that a global task force had created three separate dosing protocols: routine administration, conservative administration and rapid administration, with each designed to ease a patient treating chronic pain into medical cannabis and treatment with THC if needed. Such dosing guidelines are just half of the equation. The other half is the delivery mechanism, as…

Continue Reading